| Year |
Citation |
Score |
| 2013 |
Hamilton DH, Litzinger MT, Jales A, Huang B, Fernando RI, Hodge JW, Ardiani A, Apelian D, Schlom J, Palena C. Immunological targeting of tumor cells undergoing an epithelialmesenchymal transition via a recombinant brachyury-yeast vaccine Oncotarget. 4: 1777-1790. PMID 24125763 DOI: 10.18632/Oncotarget.1295 |
0.461 |
|
| 2013 |
Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J. Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 190: 6250-8. PMID 23677477 DOI: 10.4049/Jimmunol.1300022 |
0.583 |
|
| 2012 |
Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J. Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood. 120: 3030-8. PMID 22932804 DOI: 10.1182/Blood-2012-05-427799 |
0.578 |
|
| 2011 |
Jales A, Falahati R, Mari E, Stemmy EJ, Shen W, Southammakosane C, Herzog D, Ladisch S, Leitenberg D. Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity. Immunology. 132: 134-43. PMID 20875076 DOI: 10.1111/J.1365-2567.2010.03348.X |
0.326 |
|
| 2008 |
Thorarinsdottir HK, Santi M, McCarter R, Rushing EJ, Cornelison R, Jales A, MacDonald TJ. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3386-94. PMID 18519768 DOI: 10.1158/1078-0432.Ccr-07-1616 |
0.302 |
|
| 2008 |
Shen W, Stone K, Jales A, Leitenberg D, Ladisch S. Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides. Journal of Immunology (Baltimore, Md. : 1950). 180: 4425-32. PMID 18354163 DOI: 10.4049/Jimmunol.180.7.4425 |
0.518 |
|
| Show low-probability matches. |